Business Wire

Q4

19.8.2024 14:01:31 CEST | Business Wire | Press release

Share
Q4 Inc. Wins in International Business Awards® for 2nd Year in a Row

Q4 Inc. (“Q4” or “the company”), the IR Ops Platform, today announced it is a winner in the 2024 International Business Awards®. Honored for its “effectiveness in supporting client needs,” the company’s Web Content Services (WCS) team earned a bronze Stevie® Award for “Customer Service Team of the Year” — a category that spanned across industries — underscoring Q4’s commitment to delivering outstanding customer experiences.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240819909828/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

IBA Bronze Stevie Winner Badge (Graphic: Business Wire)

This is the second year in a row Q4 has been honored in the International Business Awards.

Considered “the Olympics for the workplace,” the International Business Awards (IBAs) are the world’s premier business awards program. All individuals and organizations worldwide – public and private, for-profit and non-profit, large and small — are eligible to submit nominations. The 2024 IBAs received entries from organizations in 62 nations and territories, with more than 3,600 nominations submitted.

Here’s what the judges had to say about Q4’s WCS team:

  • “Their achievements reflect exceptional efficiency, accuracy, and client satisfaction.”
  • “The team’s ability to handle client requests efficiently, maintain high accuracy, and achieve record CSAT scores highlights their effectiveness in supporting client needs.”
  • “Q4’s core company values shine through in the way this team operates.”
  • Q4’s WCS team shows “exceptional performance in customer service through impressive metrics, continuous improvement, and a commitment to customer satisfaction.”
  • “The WCS team at Q4 has demonstrated outstanding performance.”

“IROs and their teams have a lot on their plates, and we want to alleviate that burden through our AI-driven IR Ops Platform,” said Darrell Heaps, Founder and CEO of Q4. “This recognition from the International Business Awards shows how our amazing Web Content Services team does just that. It also highlights the high-impact results our customers achieve — using Q4 to build investor relationships and make strategic decisions. As we continue to chart a bold, new path for investor relations, we’re committed to innovation that helps IR teams realize remarkable outcomes and frees up their time to focus on what matters: strategy, relationships, and driving premium valuations for their companies.”

Q4: A single, powerful platform for investor relations

Public companies today strive to maintain up-to-date, secure and compliant investor relations websites — so they can demonstrate what they do, attract investors, and motivate them to take action. Q4’s technology makes it easy for some of the world’s biggest brands — McDonald’s, Walmart, Visa, Netflix and many more — to create and manage IR websites that drive results, accelerate website updates (publishing changes within minutes, and 16 times faster than with other tools), streamline earnings management, and tap into real-time analytics on investor behavior. With decades of website design and IR experience, Q4’s award-winning WCS team provides further assistance with website development and change requests, as well as Q4 Platform support.

Websites are just one component of Q4’s holistic IR Ops Platform, an unprecedented and unified system for attracting investors, managing relationships and staying abreast of the market’s pulse. Rather than grapple with disparate and disconnected tools, IR leaders and their companies can access everything they need from a single place: using Q4 for IR websites, virtual events, an IR CRM, surveillance, engagement analytics and more, including secure AI for IR.

Q4’s win in the International Business Awards comes on the heels of other recent milestones and momentum for the company. Q4 has powered more than 18 million investor interactions and hosts 4,400 events annually — with 530,000+ investors connecting to events via the Q4 Platform each month. Named “Best Tech-Driven Capital Markets Platform” by Global Brands Magazine, Q4 serves more than 2,600 global clients, including half of the S&P 500.

About Q4 Inc.

Q4 Inc. is the first IR Ops Platform with the world’s largest set of proprietary investor data, purpose-built to remove obstacles between public companies and their investors. Q4 gives investor relations leaders and their teams the tools to attract, manage, and understand investors — all in one place. The AI-enabled Q4 IR Ops Platform boasts applications for website and event management, engagement analytics, and earnings lifecycle management, including AI Earnings Co-Pilot to generate draft scripts based on historical data, and AI earnings call summaries to understand peer sentiment. The Platform also includes a streamlined investor CRM and shareholder intelligence with enhanced metrics to elevate investor targeting strategies. Q4 delivers the data, insights, and workflows that give IR teams the power to focus on what really matters: strategy, relationships, and driving premium valuations for their companies.

The company is a trusted partner to more than 2,600 public companies globally, including many of the most respected brands in the world, and maintains an award winning culture where team members grow and thrive.

Q4 is headquartered in Toronto, with offices in London and Copenhagen. Learn more at www.q4inc.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240819909828/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release

Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P

Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release

Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release

Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said

SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release

In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin

Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release

Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye